Blockade of the Notch Pathway by Inhibition of Fucosylation Ameliorates Chondrocyte Inflammation and Extracellular Matrix Degradation

Yunheng Zhang, Maorong Liu, Xuan Wang, N. Li, Xin Chang, Junkui Xu, Feng Tian, Xiaodong Wen, Liu C, Yi LiJournal of Inflammation Research 2025 · DOI

Abstract: Inhibition of fucosylation can ameliorate chondrocyte inflammation and extracellular matrix degradation by decreasing Notch1 activity and down-regulating the expression of the Notch pathway, which can effectively alleviate the development of OA.

Introduction

Osteoarthritis (OA) is a chronic degenerative joint disease characterized by cartilage breakdown and persistent inflammation. While current therapies often target symptoms, they fail to address the underlying biological mechanisms driving disease progression. Recent research has highlighted the role of glycosylation—specifically fucosylation—in inflammatory pathways. This study investigates how elevated fucose levels act as a regulatory switch for the Notch signaling pathway, a key driver of chondrocyte dysfunction in OA.

Methodology

The study utilized a dual-track experimental design involving both cellular and animal models:

  • In Vitro Model: Human C28 chondrocytes were treated with Interleukin-1 beta (IL-1β) to simulate OA conditions. Fucosylation was inhibited using the small molecule SGN-2FF or siRNA targeting the FUT1 gene, the enzyme responsible for adding fucose sugars.
  • In Vivo Model: OA was surgically induced in Sprague-Dawley rats via anterior cruciate ligament transection. These rats received intra-articular injections of SGN-2FF to evaluate its therapeutic potential.
  • Analytical Techniques: The researchers employed lectin blotting to detect fucose-modified proteins, Western blotting for Notch pathway components (NICD, HES1), and histological analysis (OARSI scoring) to assess cartilage integrity.

Key Results

The investigation revealed that fucosylation is essential for Notch1 receptor activation. In inflammatory environments, fucose levels are significantly elevated, promoting the activation of the Notch pathway.

Comprehensive analysis of IL-1β induced inflammation and the effects of fucosylation inhibition in C28 chondrocytes.

As shown in the figure above, IL-1β treatment significantly reduced cell viability and increased the expression of inflammatory markers like IL-6. Crucially, lectin blotting (Panel F) confirmed an increase in fucosylated proteins under inflammatory conditions. Inhibition of fucosylation via SGN-2FF successfully suppressed the Notch pathway, leading to several key outcomes:

  • Reduced Inflammation: Treatment led to a significant drop in pro-inflammatory cytokines, including IL-6 and TNF-α.
  • Matrix Protection: Downregulation of matrix metalloproteinases (MMP-9, MMP-13) helped preserve the extracellular matrix scaffolding.
  • Structural Preservation: In rat models, high-dose SGN-2FF treatment resulted in higher Bone Volume Fraction (BV/TV) and improved cartilage morphology compared to untreated OA groups.

Discussion and Conclusion

This study identifies the fucose-Notch axis as a critical therapeutic target in OA. By blocking the addition of fucose sugars to the Notch1 receptor, researchers were able to halt the inflammatory cascade and protect cartilage from degradation. While SGN-2FF shows promise, the authors note that future research must address potential systemic side effects and optimize local delivery methods to the joint. Overall, inhibiting fucosylation represents a novel strategy to transition from symptom management to disease modification in osteoarthritis.

Summary updated

Abstract

Inhibition of fucosylation can ameliorate chondrocyte inflammation and extracellular matrix degradation by decreasing Notch1 activity and down-regulating the expression of the Notch pathway, which can effectively alleviate the development of OA.
BibTeX
@article{zhang2025blockade,
  author = {Yunheng Zhang and Maorong Liu and Xuan Wang and N. Li and Xin Chang and Junkui Xu and Feng Tian and Xiaodong Wen and Liu C and Yi Li},
  title = {{Blockade of the Notch Pathway by Inhibition of Fucosylation Ameliorates Chondrocyte Inflammation and Extracellular Matrix Degradation}},
  journal = {Journal of Inflammation Research},
  year = {2025},
  doi = {10.2147/jir.s520179},
}
Figure